Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period September 201620172018201920202021
Sales1 0881 1901 2811 4081 5351 660
EBITDA175205228271301333
Operating profit (EBIT)154181197237267299
Pre-Tax Profit (EBT)142189179233269304
Net income98,3134126161188213
P/E ratio28,128,151,449,541,436,2
EPS ( € )1,211,571,411,762,112,41
Dividend per Share ( € )0,420,550,550,610,720,78
Yield1,23%1,25%0,76%0,70%0,82%0,90%
Reference price ( € )34.0344.16572.587.287.287.2
Announcement Date12/09/2016
09:30am
12/08/2017
04:00pm
12/07/2018
06:08am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period September 201620172018201920202021
Debt------
Finance335253324663737747
Operating income (EBITDA)175205228271301333
Leverage
(Debt/EBITDA)
------
Capital Expenditure12,813,716,528,530,734,4
Book Value Per Share (BVPS)9,81 €13,6 €15,1 €15,8 €17,3 €19,1 €
Cash Flow per Share1,37 €0,44 €2,18 €1,96 €2,08 €2,40 €
Announcement Date12/09/2016
09:30am
12/08/2017
04:00pm
12/07/2018
06:08am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 7 799 M€ -
Entreprise Value (EV) 7 136 M€ 7 062 M€
Valuation 2019e 2020e
P/E ratio (Price / EPS) 49,5x 41,4x
Capitalization / Revenue 5,54x 5,08x
EV / Revenue 5,07x 4,60x
EV / EBITDA 26,4x 23,5x
Yield (DPS / Price) 0,70% 0,82%
Price to book (Price / BVPS) 5,53x 5,03x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 16,8% 17,4%
operating Leverage (Delta EBIT / Delta Sales) 2,04x 1,42x
Net Margin (Net Profit / Revenue) 11,4% 12,2%
ROA (Net Profit / Asset) 9,43% 10,2%
ROE (Net Profit / Equities) 11,5% 12,5%
Rate of Dividend 34,8% 34,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   2,03% 2,00%
Cash Flow / Sales 12,5% 12,1%
Capital Intensity (Assets / Sales) 1,21x 1,20x
Financial Leverage (Net Debt / EBITDA) -2,45x -2,45x
EPS & Dividend